ProMetic Life Sciences Inc. completes C$23.9 million marketed offering

Date Closed: 11/07/2013

Value: C$23.9 million

BLG acted for ProMetic Life Sciences Inc. in respect of its short form prospectus offering of 26,651,400 common shares at a price of $0.90 per share for total gross proceeds of $23.986,260. The offering was conducted on a best efforts basis by a syndicate of agents led by Paradigm Capital Inc. and including Beacon Securities Limited, D&D Securities Inc. and Cormark Securities Inc.

BLG’s deal team included Pascal de Guise, Yaniv Saragosti and Réda Ray Saad.